[Spacewalk-list] Foreign packages leaked to RHEL Channel
Jens Neu
jens.neu at biotronik.com
Wed Mar 14 14:37:53 UTC 2012
Dear all,
I am running Spacewalk 1.5 (on CentOS 5.7, against full Oracle 11g) with
Centos 5, 6 and Fedora 16 Channels for some time now. I also use the
centos-errata.py (0.8.1) script (
https://github.com/davidnutter/Centos-Errata) to import CentOS Errata
which works fine for me.
Additionally I have several RHEL 5 machines with valid subscriptions,
these I run against mrepo on one of them. Now, I would like the RHEL 5
machines also be managed with Spacewalk, so I created a RHEL 5 Channel,
synced it to my local mrepo, fired up rhn-clone-errata.py; easy enough,
piece of cake, seemed to work fine.
But: for some reason I see CentOS packages in my freshly created RHEL
Channel. This thread
https://www.redhat.com/archives/spacewalk-list/2011-August/msg00149.html
tells me that I'm not crazy, and since the CentOS Packages show up after
Errata publishing I also had a suspicion about whats going on.
Now: how can I fix this? This behaviour pretty much prevents running RHEL
and CentOS Channels on a single Spacewalk...
best regards
Jens
Jens Neu
Health Services Network Administration
Phone: +49 (0) 30 68905-2412
Mail: jens.neu at biotronik.de
www.biotronik.com
BIOTRONIK SE & Co. KG
Woermannkehre 1, 12359 Berlin, Germany
Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRA 6501
Vertreten durch ihre Komplementärin:
BIOTRONIK MT SE
Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRB 118866 B
Geschäftsführende Direktoren: Christoph Böhmer, Dr. Werner Braun, Dr.
Lothar Krings
BIOTRONIK - A global manufacturer of advanced Cardiac Rhythm Management
systems and Vascular Intervention devices. Quality, innovation, and
reliability define BIOTRONIK and our growing success. We are innovators of
technologies like the first wireless remote monitoring system - Home
Monitoring®, Closed Loop Stimulation and coveted lead solutions as well as
state-of-the-art stents, balloons and guide wires for coronary and
peripheral indications. We highly invest in the development of drug
eluting devices and are leading the industry with our drug eluting
absorbable metal scaffold program.
This e-mail and the information it contains including attachments are
confidential and meant only for use by the intended recipient(s);
disclosure or copying is strictly prohibited. If you are not addressed,
but in the possession of this e-mail, please notify the sender immediately
and delete the document.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://listman.redhat.com/archives/spacewalk-list/attachments/20120314/7a183d4a/attachment.htm>
More information about the Spacewalk-list
mailing list